As of Jul 07
| +0.93 / +1.10%|
The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 103.00, with a high estimate of 125.00 and a low estimate of 92.00. The median estimate represents a +20.10% increase from the last price of 85.76.
The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.